[ad_1] By Adria Calatayud Nestle said it has sold its Palforzia peanut-allergy treatment business to biopharmaceutical company Stallergenes Greer. The Swiss consumer-goods company said Monday that...
[ad_1] Nestle SA has lifted its full-year organic sales-growth guidance and outlined targets for 2025 ahead of its investor seminar on Tuesday. The Swiss packaged-foods giant...